ArticleBioMed research international2017

CYP1B1 G199T Polymorphism Affects Prognosis of NSCLC Patients with the Potential to Be an Indicator and Target for Precise Drug Intervention.

Fengzhou Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.